BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27891738)

  • 1. Treatment of prurigo nodularis with lenalidomide.
    Ossorio-García L; Jiménez-Gallo D; Rodríguez-Mateos ME; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lenalidomide in treating refractory prurigo nodularis.
    Liu H; Gaspari AA; Schleichert R
    J Drugs Dermatol; 2013 Mar; 12(3):360-1. PubMed ID: 23545923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory prurigo nodularis with lenalidomide.
    Kanavy H; Bahner J; Korman NJ
    Arch Dermatol; 2012 Jul; 148(7):794-6. PubMed ID: 22801610
    [No Abstract]   [Full Text] [Related]  

  • 4. A Review of the Efficacy of Thalidomide and Lenalidomide in the Treatment of Refractory Prurigo Nodularis.
    Lim VM; Maranda EL; Patel V; Simmons BJ; Jimenez JJ
    Dermatol Ther (Heidelb); 2016 Sep; 6(3):397-411. PubMed ID: 27289372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide for the treatment of chronic refractory prurigo nodularis.
    Aguh C; Kwatra SG; He A; Okoye GA
    Dermatol Online J; 2018 Mar; 24(3):. PubMed ID: 29634881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prurigo nodularis of Hyde treated with low-dose thalidomide.
    Orlando A; Renna S; Cottone M
    Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prurigo nodularis: a review.
    Lee MR; Shumack S
    Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide in 42 patients with prurigo nodularis Hyde.
    Andersen TP; Fogh K
    Dermatology; 2011; 223(2):107-12. PubMed ID: 21952556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide.
    Lan CC; Lin CL; Wu CS; Chai CY; Chen WT; Chen GS
    J Dermatol; 2007 Apr; 34(4):237-42. PubMed ID: 17352720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review of dupilumab for adult patients with prurigo nodularis.
    Biazus Soares G; Yosipovitch G
    Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-resistant prurigo nodularis: challenges and solutions.
    Kowalski EH; Kneiber D; Valdebran M; Patel U; Amber KT
    Clin Cosmet Investig Dermatol; 2019; 12():163-172. PubMed ID: 30881076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis.
    Ferrándiz C; Carrascosa JM; Just M; Bielsa I; Ribera M
    Dermatology; 1997; 195(4):359-61. PubMed ID: 9529557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prurigo nodularis and Hashimoto thyroiditis.
    Rishi R; Ringwala S; Tracy J; Fatteh S
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):673-4. PubMed ID: 25446192
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.
    Maurer T; Poncelet A; Berger T
    Arch Dermatol; 2004 Jul; 140(7):845-9. PubMed ID: 15262695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.
    Williams KA; Roh YS; Brown I; Sutaria N; Bakhshi P; Choi J; Gabriel S; Chavda R; Kwatra SG
    Expert Rev Clin Pharmacol; 2021 Jan; 14(1):67-77. PubMed ID: 33191806
    [No Abstract]   [Full Text] [Related]  

  • 16. Thalidomide treatment of prurigo nodularis.
    Winkelmann RK; Connolly SM; Doyle JA; Padilha-Goncalves A
    Acta Derm Venereol; 1984; 64(5):412-7. PubMed ID: 6208720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of prurigo nodularis with thalidomide.
    van den Broek H
    Arch Dermatol; 1980 May; 116(5):571-2. PubMed ID: 7377791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.
    Vaidya DC; Schwartz RA
    Acta Dermatovenerol Croat; 2008; 16(1):38-44. PubMed ID: 18358109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series.
    Siepmann D; Luger TA; Ständer S
    J Dtsch Dermatol Ges; 2008 Nov; 6(11):941-6. PubMed ID: 18445069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.
    Pereira MP; Basta S; Moore J; Ständer S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2224-2229. PubMed ID: 29869425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.